Skip to main content

Table 1 Patients' characteristics of 160 patients treated with radiation and temozolomide for primary glioblastoma.

From: Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?

Characteristic

N (%)

Age - years

 

median

56

range

20-76

Age - no. (%)

 

< 50

38 (24)

≥ 50

122 (76)

Sex - number (%)

 

female

66 (41)

male

94 (59)

Karnofsky Performance Score

 

≥ 70

115 (72)

< 70

45 (28)

Extent of surgery - no. (%)

 

biopsy

43 (27)

complete resection

51 (32)

partial resection

66 (41)

RPA/EORTC-Classification

 

III

33 (21)

IV

90 (56)

V

37 (23)

Time from diagnosis to RT - days

 

median

24

range

7-98

Corticosteroid therapy - no. (%)

 

yes

113 (71)

no

47 (29)

Anti-seizure medication - no. (%)

 

yes

75 (47)

no

85 (53)